APA (7th ed.) Citation

KJ, D., A, G., L, S., RC, R., AF, Z., & MR, G. (2022). A Pharmacokinetic Analysis of Tobramycin in Patients Less than Five Years of Age with Cystic Fibrosis: Assessment of Target Attainment with Extended-Interval Dosing through Simulation. Antimicrobial agents and chemotherapy, 66(5), e0237721. https://doi.org/10.1128/aac.02377-21

Chicago Style (17th ed.) Citation

KJ, Downes, Grim A, Shanley L, Rubenstein RC, Zuppa AF, and Gastonguay MR. "A Pharmacokinetic Analysis of Tobramycin in Patients Less than Five Years of Age with Cystic Fibrosis: Assessment of Target Attainment with Extended-Interval Dosing Through Simulation." Antimicrobial Agents and Chemotherapy 66, no. 5 (2022): e0237721. https://doi.org/10.1128/aac.02377-21.

MLA (9th ed.) Citation

KJ, Downes, et al. "A Pharmacokinetic Analysis of Tobramycin in Patients Less than Five Years of Age with Cystic Fibrosis: Assessment of Target Attainment with Extended-Interval Dosing Through Simulation." Antimicrobial Agents and Chemotherapy, vol. 66, no. 5, 2022, p. e0237721, https://doi.org/10.1128/aac.02377-21.